Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07158151
PHASE2

A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

Sponsor: Reistone Biopharma Company Limited

View on ClinicalTrials.gov

Summary

This study is ongoing to explore the efficacy and safety of different strengths of RSS0393 ointment in adults with atopic dermatitis

Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of RSS0393 Ointment in Adults With Mild to Moderate Atopic Dermatitis

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

168

Start Date

2025-09-25

Completion Date

2026-05

Last Updated

2026-01-29

Healthy Volunteers

No

Interventions

DRUG

RSS0393 ointment

RSS0393 ointment 0.05%

DRUG

RSS0393 ointment

RSS0393 ointment 0.01%

DRUG

RSS0393 ointment

RSS0393 ointment 0.03%

DRUG

RSS0393 ointment

RSS0393 ointment placebo

Locations (1)

Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, China